Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith C Ferdinand

Showing results (61-70 of 287) with videos related to

Pageof 29
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|March 12, 2019
Improved pathways to hypertension control and elimination of disparities: Are we there yet?Keith C Ferdinand, Carola Maraboto
Journal of the American College of Cardiology|October 29, 2025
Ushering in a New Approach for Primary Prevention: Guidelines for Assessing Cardiovascular RiskEugene Yang, Keith C Ferdinand
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
SGLT2 inhibition for outcomes: Is this the panacea?Keith C Ferdinand, Neha Arora
American Heart Journal Plus : Cardiology Research and Practice|March 21, 2024
The time is now: Identification and modification of disparities in cardiovascular diseaseKeith C Ferdinand, Daniel Harrison
Annals of Translational Medicine|December 30, 2017
Cardiovascular outcome studies with glucagon-like peptide 1 receptor agonists-what will REWIND add?Keith C Ferdinand, Indrajeet Mahata
Journal of the American Heart Association|April 5, 2019
Is Electrocardiography-Left Ventricular Hypertrophy an Obsolete Marker for Determining Heart Failure Risk With Hypertension?Keith C Ferdinand, Carola Maraboto
American Heart Journal Plus : Cardiology Research and Practice|October 8, 2024
OCEANIC-AF and the inferior efficacy of asundexian compared to apixaban in patients at high risk with atrial fibrillation: Have we come to the end of the road for factor XIa inhibitors?Keith C Ferdinand, Asaad Nakhle
Expert Review of Clinical Pharmacology|August 14, 2018
The role of racial/ethnic factors in global clinical trialsKeith C Ferdinand, Miyako Igari
American Heart Journal Plus : Cardiology Research and Practice|March 21, 2024
Primordial prevention: Reducing consumption of sugar-sweetened beverages in racial/ethnic populationsVi Nguyen, Keith C Ferdinand
Journal of the National Medical Association|June 11, 2016
Race/Ethnicity in Atrial Fibrillation Stroke: Epidemiology and PharmacotherapyKeith C Ferdinand, Gary A Puckrein
Pageof 29

Showing results (61-70 of 287) with videos related to

Sort By:
Pageof 29
Journal of Clinical Hypertension (Greenwich, Conn.)|March 12, 2019
Improved pathways to hypertension control and elimination of disparities: Are we there yet?Keith C Ferdinand, Carola Maraboto
Journal of the American College of Cardiology|October 29, 2025
Ushering in a New Approach for Primary Prevention: Guidelines for Assessing Cardiovascular RiskEugene Yang, Keith C Ferdinand
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
SGLT2 inhibition for outcomes: Is this the panacea?Keith C Ferdinand, Neha Arora
American Heart Journal Plus : Cardiology Research and Practice|March 21, 2024
The time is now: Identification and modification of disparities in cardiovascular diseaseKeith C Ferdinand, Daniel Harrison
Annals of Translational Medicine|December 30, 2017
Cardiovascular outcome studies with glucagon-like peptide 1 receptor agonists-what will REWIND add?Keith C Ferdinand, Indrajeet Mahata
Journal of the American Heart Association|April 5, 2019
Is Electrocardiography-Left Ventricular Hypertrophy an Obsolete Marker for Determining Heart Failure Risk With Hypertension?Keith C Ferdinand, Carola Maraboto
American Heart Journal Plus : Cardiology Research and Practice|October 8, 2024
OCEANIC-AF and the inferior efficacy of asundexian compared to apixaban in patients at high risk with atrial fibrillation: Have we come to the end of the road for factor XIa inhibitors?Keith C Ferdinand, Asaad Nakhle
Expert Review of Clinical Pharmacology|August 14, 2018
The role of racial/ethnic factors in global clinical trialsKeith C Ferdinand, Miyako Igari
American Heart Journal Plus : Cardiology Research and Practice|March 21, 2024
Primordial prevention: Reducing consumption of sugar-sweetened beverages in racial/ethnic populationsVi Nguyen, Keith C Ferdinand
Journal of the National Medical Association|June 11, 2016
Race/Ethnicity in Atrial Fibrillation Stroke: Epidemiology and PharmacotherapyKeith C Ferdinand, Gary A Puckrein
Pageof 29